Skip to main content
Premium Trial:

Request an Annual Quote

RainDance Signs JCVI as Early Access Partner for Sequence-Enrichment Technology

NEW YORK (GenomeWeb News) – RainDance Technologies said today that it has signed the J. Craig Venter Institute as an early-access partner for its microfluidics-based sequence-enrichment technology for next-generation sequencing.
 
Under the terms of the agreement, JCVI will have access to the company’s RDT 1000 instrument and Sequence Enrichment application, which are based on RainDance's RainStorm droplet-based technology platform.
 
The RDT 1000 generates picoliter-volume PCR reactions at a rate of 10 million reactions per hour, and the Sequence Enrichment application uses a library of PCR primers in droplets to amplify hundreds to thousands of genomic loci in a single tube, the company said.
 
Under the early-access agreement, RainDance said it is providing the RDT 1000 instrument, training, and customized PCR primer libraries designed to selectively amplify loci of interest for research initiatives at JCVI.
 
Robert Strausberg, deputy director and group leader in genomic medicine at JCVI, said in a statement that the institute’s scientists will use the RainDance technology in “various large-scale targeted sequencing studies.”
 
RainDance expects to launch the system commercially in the first quarter of 2009.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.